Suppr超能文献

[肝硬化无低钠血症及肾功能不全患者腹水的治疗。比较利尿剂与白蛋白补偿穿刺术的随机研究结果]

[Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].

作者信息

Hagège H, Ink O, Ducreux M, Pelletier G, Buffet C, Etienne J P

机构信息

Service des Maladies du Foie et de l'Appareil Digestif, Centre Hospitalier de Bicêtre, Le Kremlin-Bicêtre.

出版信息

Gastroenterol Clin Biol. 1992;16(10):751-5.

PMID:1478401
Abstract

Previous studies have suggested that treatment of ascites in cirrhotic patients by repeated paracenteses and albumin infusion is fast, effective and safe. In one of these studies including patients with hyponatremia or renal impairment, this treatment was associated with a reduction of duration of hospital stay in comparison with large dose diuretics. The aim of this randomized study was to compare paracentesis with albumin perfusion and low dose diuretics in cirrhotic patients with ascites, but without hyponatremia or renal impairment. Twenty-six patients (group 1) were treated with paracentesis (4 L/day) and 27 patients (group 2) were treated with spironolactone (225 to 300 mg/day), associated with furosemide (40 to 80 mg/day), when inefficient alone. Ascites and peripheric edema disappeared more rapidly in group 1 than in group 2, 8.6 +/- 9.6 vs 13.5 +/- 6.7 days (P = 0.001) and 4.1 +/- 2.6 vs 10.5 +/- 6.5 days (P = 0.001) respectively. During hospitalisation, the incidence of complications was higher in group 2 than in group 1: 56 vs 26% (P = 0.03). Hyponatremia occurred in 30% of patients in group 2 and 4% of patients in group 1 (P = 0.04). The duration of hospital stay was shorter in group 1 (15.0 +/- 10.4 days) than in group 2 (21.0 +/- 11.7 days) (P = 0.007). During follow-up, ascites reappeared in 32% of patients in group 1 and 57% of patients in group 2 (P = 0.09). At 3 months, one patient in group 1 and 2 patients in group 2 developed spontaneous peritonitis whereas survival was similar in both groups.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

以往研究表明,通过反复穿刺放腹水及输注白蛋白治疗肝硬化患者的腹水,快速、有效且安全。其中一项纳入低钠血症或肾功能损害患者的研究显示,与大剂量利尿剂相比,该治疗可缩短住院时间。本随机研究旨在比较穿刺放腹水联合白蛋白灌注与小剂量利尿剂治疗无低钠血症或肾功能损害的肝硬化腹水患者的疗效。26例患者(第1组)接受穿刺放腹水治疗(每日4升),27例患者(第2组)接受螺内酯(每日225至300毫克)治疗,单用无效时加用呋塞米(每日40至80毫克)。第1组腹水和外周水肿消失速度比第2组更快,分别为8.6±9.6天对13.5±6.7天(P = 0.001)和4.1±2.6天对10.5±6.5天(P = 0.001)。住院期间,第2组并发症发生率高于第1组:56%对26%(P = 0.03)。第2组30%的患者发生低钠血症,第1组为4%(P = 0.04)。第1组住院时间(15.0±10.4天)短于第2组(21.0±11.7天)(P = 0.007)。随访期间,第1组32%的患者腹水复发,第2组为57%(P = 0.09)。3个月时,第1组1例患者和第2组2例患者发生自发性腹膜炎,两组生存率相似。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验